Mesoblast Limited (ASX:MSB)

Mesoblast Revenue

In the fiscal year ending June 30, 2025, Mesoblast had annual revenue of $17.2 million USD with 191.39% growth. Mesoblast had revenue of $14.04 million in the half year ending June 30, 2025, with 244.25% growth.

• Revenue: $17.20M
• Revenue Growth: +191.39%
• P/S Ratio: 127.84
• Revenue / Employee: $212.32K
• Employees: 81
• Market Cap: 3.35B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	17.20M	11.30M	191.39%
Jun 30, 2024	5.90M	-1.60M	-21.32%
Jun 30, 2023	7.50M	-2.71M	-26.54%
Jun 30, 2022	10.21M	2.78M	37.36%
Jun 30, 2021	7.43M	-24.72M	-76.88%